BioCentury
ARTICLE | Clinical News

RUT58-60: Phase I/II started

November 3, 2014 8:00 AM UTC

Ruthigen began a double-blind, U.S. Phase I/II trial to evaluate RUT58-60 in about 150 patients undergoing abdominal surgery. Prior to closure of the abdomen at the end of surgery, patients will under...